Malignant Pleural Mesothelioma Nodal Status: Where Are We at?

Due to the lack of both prospective trial and high-volume retrospective studies, the management of clinical N+ malignant pleural mesothelioma (MPM) patients remains highly debated. Node positive patients show poor survival compared with node-negative ones; thus, lymph node staging appears crucial in...

Descripción completa

Detalles Bibliográficos
Autores principales: Ricciardi, Sara, Carleo, Francesco, Jaus, Massimo O., Di Martino, Marco, Carbone, Luigi, Ricci, Alberto, Cardillo, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584902/
https://www.ncbi.nlm.nih.gov/pubmed/34768701
http://dx.doi.org/10.3390/jcm10215177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584902/
https://www.ncbi.nlm.nih.gov/pubmed/34768701
http://dx.doi.org/10.3390/jcm10215177

Ejemplares similares